Novel application of autologous micrografts in a collagen-glycosaminoglycan scaffold for diabetic wound healing

Abstract

Therapeutic strategies that successfully combine two techniques—autologous micrografting and biodegradable scaffolds—offer great potential for improved wound repair and decreased scarring. In this study we evaluate the efficacy of a novel modification of a collagen-glycosaminoglycan (collagen-GAG) scaffold with autologous micrografts using a murine dorsal wound model. db/db mice underwent a full thickness 1.0 cm2 dorsal wound excision and were treated with a collagen-GAG scaffold (CGS group), a modified collagen-GAG scaffold (CGS + MG group) or simple occlusive dressing (Blank group). The modified scaffold was created by harvesting full thickness micrografts and transplanting these into the collagen-GAG membrane. Parameters of wound healing, including cellular proliferation, collagen deposition, keratinocyte migration, and angiogenesis were assessed. The group treated with the micrograft-modified scaffold healed at a faster rate, showed greater cellular proliferation, collagen deposition, and keratinocyte migration with higher density and greater maturity of microvessels. The grafts remained viable within the scaffold with no evidence of rejection. Keratinocytes were shown to migrate from the wound border and from the micrograft edges towards the center of the wound, while cellular proliferation was present both at the wound border and wound bed. We report successful treatment of diabetic wounds with a novel collagen-GAG scaffold modified with full-thickness automicrografts. Differences in cellular migration and proliferation offer maiden evidence on the mechanisms of wound healing. Clinically, the successful scaffold engraftment, micrograft viability and improved wound healing offer promising results for the development of a new therapeutic modality for wound repair.